1) Increasing circulating sphingosine-1-phosphate attenuates lung injury during ex vivo lung perfusion. Mehaffey JH, Charles EJ, Narahari AK, Schubert S, Zhao Y, Laubach VE, Roeser ME, Lynch KR, Kron IL, Sharma AK.; J. Thorac. Cardio. Surg.; Aug;156(2):910-917
2) Invited Commentary. Sharma AK and Upchurch, GR, Jr. J Vasc. Surg. 2018; In Press.
3) Pannexin-1 channel inhibition on endothelial cells mitigates lung ischemia-reperfusion injury. Sharma AK, Charles E, Zhao Y, Narahari AK, Bayliss DA, Kron IL, Ravichandran KS, Isakson B and Laubach VE. American Journal of Physiology (Lung); Aug 1;315(2):L301-L312.
4) Human mesenchymal stem cell-derived extracellular vesicles attenuate aortic aneurysm formation and smooth muscle activation via microRNA-147. Lu G, Salmon MD, Gehrau R, Su G, Smith JR, Weiss ML, Mas VR, Upchurch GR, Jr., Sharma AK. FASEB; In Press; doi: 10.1096/fj.201701138RR.
5) Tamsulosin attenuates abdominal aortic growth. Montgomery WG, Spinosa MD, Cullen JM, Salmon M, Su G, Hassinger T, Sharma AK, Lu G, Fashandi A, Ailawadi G and Upchurch Gr, Jr. Surgery; In Press.
6) Can lung transplant surgeons still be scientists? High productivity despite competitive funding. Narahari AK, Charles EJ, Mehaffey JH, Hawkins RB, Sharma AK, Laubach VE, Tribble CG, Kron IL. The Heart Surgery Forum; In Press.
7) ZFP148 binds with NF-1 to inhibit Smooth Muscle Marker genes Expression and Activates p21 and BAK promoters during Abdominal Aortic Aneurysm Formation. Salmon M, Schaheen B, Pope N, Davis J, Johnston W, Sharma AK, Owens GK, Merchant J, Zehner Z, Upchurch GR, Ailawadi G. Arterio, Thromb. Vascul. Biol.; In Press.
8) A novel swine model of abdominal aortic aneurysm. Cullen MJ, Lu G, Shannon A, Su G, Sharma AK, Salmon MD, Montgomery WG, Johnston W, Ailawadi G, Upchurch GR. J Vascular Surgery; In Press.
